Drug to reverse breast cancer spread in development

Sounds good. 

Guess what I'm hoping for, is somewhere down the road, the term "regression" is used.

There is no drug developed yed. Tiziana pharmaceuticals is trying to develop the drug.

@Srh242, the article says 

"...the group identified a pocket on the surface of the gene that is essential for its function.
They then identifed a drug that could inhibit the way the gene works.
When the compound was trialed on mice with metastatic disease,
researchers found the drug completely stopped the development of the
mice’s metastatic tumours.
The team are now working to test the compound in clinical trials..."

I want to know the name of what is referred to as "a drug" or "the compound" so I can look for more information and followup stories online. Since this is all happening in the UK, I don't imagine I will be able to participate in any of the clinical trials, but I would like to keep track of the further testing of this drug to see if it works on people as well as it did on the mice.

@leggo, I'd like to see the word "regression" too. The headlines use the word "reverse" but the text of the story doesn't say spread was reveresed, only that it was halted. 

Another thing I'd like to know that isn't mentioned in the article...it says this compound completely stopped the development of the metastatic tumors. Do they mean permanently stopped, as long as the mice continued to receive the drug? Or is this another treatment like others, that after a while stops working?

Check this link out: http://courses.cardiff?ac.uk/funding/R452.htm

Probably they are not going to say the name of the compound, so they can sell it to big pharma.

I finally found the article in Cancer Research Journal. The title is "Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors", and it was published in January of last year. If you have access to PubMed (often available through public libraries)
there's a link to the full text of the article. I haven't read it yet
and don't know if I will understand it when I do.

I guess what is new and prompted all the press releases this weekend is that Tiziana Pharmaceuticals has agreed to fund clinical trials of the drug that was tested earlier on mice.

I found an address but no phone number. It looks like a small company. Weird.

I thought it was based in England,

For all I know, the pharma arm of this company is in England. There is so much about this that's ambiguous. Hopefully, they'll pick up their phone at some point. 

hope its a major find ......this disease took my sister last year

Apparently, the drug company is even "still in development", so I'm thinking it will be a long time before it sees the light of day. Since the compound and research is "owned" by a bio-tech company working on developing a pharmaceutical company, I'm not feeling to confident. I think money will be the deciding factor. So hope I'm wrong.